Evidence map›Paper›PMID 35344448›Full record

ArticleJCO precision oncology2022

Exploring Survival Outcomes in Metastatic Colorectal Cancer Harboring KRAS A146 Mutations: Important Distinction or Simple Distraction?

Richard Pham, Azim Jalali, Chia Chong, Vanessa Wong, Kate Dunn, Peter Gibbs

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in JCO precision oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Richard PhamRichard Pham, MBBS, Epworth Healthcare, Melbourne, Australia WEHI, Melbourne, Australia and Azim Jalali, MBBS, Chia Chong, MBBS, Vanessa Wong, MBBS, Kate Dunn, MBBS, and Peter Gibbs, MBBS, Personalised Oncology Division, WEHI.ORCID 0000-0003-4973-1595
Azim JalaliRichard Pham, MBBS, Epworth Healthcare, Melbourne, Australia WEHI, Melbourne, Australia and Azim Jalali, MBBS, Chia Chong, MBBS, Vanessa Wong, MBBS, Kate Dunn, MBBS, and Peter Gibbs, MBBS, Personalised Oncology Division, WEHI.
Chia ChongRichard Pham, MBBS, Epworth Healthcare, Melbourne, Australia WEHI, Melbourne, Australia and Azim Jalali, MBBS, Chia Chong, MBBS, Vanessa Wong, MBBS, Kate Dunn, MBBS, and Peter Gibbs, MBBS, Personalised Oncology Division, WEHI.ORCID 0000-0002-7584-967X
Vanessa WongRichard Pham, MBBS, Epworth Healthcare, Melbourne, Australia WEHI, Melbourne, Australia and Azim Jalali, MBBS, Chia Chong, MBBS, Vanessa Wong, MBBS, Kate Dunn, MBBS, and Peter Gibbs, MBBS, Personalised Oncology Division, WEHI.ORCID 0000-0002-4323-8786
Kate DunnRichard Pham, MBBS, Epworth Healthcare, Melbourne, Australia WEHI, Melbourne, Australia and Azim Jalali, MBBS, Chia Chong, MBBS, Vanessa Wong, MBBS, Kate Dunn, MBBS, and Peter Gibbs, MBBS, Personalised Oncology Division, WEHI.ORCID 0000-0002-3663-4406
Peter GibbsRichard Pham, MBBS, Epworth Healthcare, Melbourne, Australia WEHI, Melbourne, Australia and Azim Jalali, MBBS, Chia Chong, MBBS, Vanessa Wong, MBBS, Kate Dunn, MBBS, and Peter Gibbs, MBBS, Personalised Oncology Division, WEHI.ORCID 0000-0003-1423-4484

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Colonic NeoplasmsProto-Oncogene Proteins p21(ras)HumansMutationras ProteinsKRAS protein, humanProto-Oncogene Proteins p21(ras)ras Proteins

Identifiers

PMID35344448

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.